Compare POWW & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POWW | RPID |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Ordnance And Accessories | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.8M | 204.3M |
| IPO Year | N/A | 2021 |
| Metric | POWW | RPID |
|---|---|---|
| Price | $2.36 | $1.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.40 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 691.6K | 133.5K |
| Earning Date | 02-09-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | $14.56 | $19.12 |
| Revenue Next Year | $0.50 | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $1.08 | $1.66 |
| 52 Week High | $2.46 | $4.94 |
| Indicator | POWW | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 74.11 | 30.06 |
| Support Level | $1.94 | $1.66 |
| Resistance Level | N/A | $2.46 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 78.00 | 4.90 |
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.